LncRNA Profiling Reveals That the Deregulation of H19, WT1-AS, TCL6, and LEF1-AS1 Is Associated with Higher-Risk Myelodysplastic Syndrome
Authors:
- Katarina SzikszaiKSKatarina Szikszai
- Zdenek KrejcikZKZdenek Krejcik
- Jiri KlemaJKJiri Klema
- Nikoleta LoudovaNLNikoleta Loudova
- Andrea HrustincovaAHAndrea Hrustincova
- Monika BelickovaMBMonika Belickova
- Monika HrubaMHMonika Hruba
- Jitka VeselaJVJitka Vesela
- Viktor StraneckyVSViktor Stranecky
- David KundratDKDavid Kundrat
- Pavla PecherkovaPPPavla Pecherkova
- Jaroslav CermakJCJaroslav Cermak
Open Access
Abstract
Background: myelodysplastic syndrome (MDS) is a hematopoietic stem cell disorder with an incompletely known pathogenesis. Long noncoding RNAs (lncRNAs) play multiple roles in hematopoiesis and represent a new class of biomarkers and therapeutic targets, but information on their roles in MDS is limited. Aims: here, we aimed to characterize lncRNAs deregulated in MDS that may function in disease pathogenesis. In particular, we focused on the identification of lncRNAs that could serve as novel potential biomarkers of adverse outcomes in MDS. Methods: we performed microarray expression profiling of lncRNAs and protein-coding genes (PCGs) in the CD34+ bone marrow cells of MDS patients. Expression profiles were analyzed in relation to different aspects of the disease (i.e., diagnosis, disease subtypes, cytogenetic and mutational aberrations, and risk of progression). LncRNA-PCG networks were constructed to link deregulated lncRNAs with regulatory mechanisms associated with MDS. Results: we found several lncRNAs strongly associated with disease pathogenesis (e.g., H19, WT1-AS, TCL6, LEF1-AS1, EPB41L4A-AS1, PVT1, GAS5, and ZFAS1). Of these, downregulation of LEF1-AS1 and TCL6 and upregulation of H19 and WT1-AS were associated with adverse outcomes in MDS patients. Multivariate analysis revealed that the predominant variables predictive of survival are blast count, H19 level, and TP53 mutation. Coexpression network data suggested that prognosis-related lncRNAs are predominantly related to cell adhesion and differentiation processes (H19 and WT1-AS) and mechanisms such as chromatin modification, cytokine response, and cell proliferation and death (LEF1-AS1 and TCL6). In addition, we observed that transcriptional regulation in the H19/IGF2 region is disrupted in higher-risk MDS, and discordant expression in this locus is associated with worse outcomes. Conclusions: we identified specific lncRNAs contributing to MDS pathogenesis and proposed cellular processes associated with these transcripts. Of the lncRNAs associated with patient prognosis, the level of H19 transcript might serve as a robust marker comparable to the clinical variables currently used for patient stratification.Keywords
Funding Information
- Agentura Pro Zdravotnický Výzkum České Republiky (17-31398A)
- Grantová Agentura České Republiky (20-19162S)
- Ministerstvo Zdravotnictví Ceské Republiky (00023736)
This publication has 35 references indexed in Scilit:
- The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expressionGenome Research, 2012
- Differential Expression of MicroRNAs in CD34+ Cells of 5q- SyndromeJournal of Hematology & Oncology, 2011
- Distinctive microRNA expression profiles in CD34+ bone marrow cells from patients with myelodysplastic syndromeEuropean Journal of Human Genetics, 2010
- WT1 expression levels at diagnosis could predict long‐term time‐to‐progression in adult patients affected by acute myeloid leukaemia and myelodysplastic syndromesBritish Journal of Haematology, 2010
- Alternately spliced WT1 antisense transcripts interact with WT1 sense RNA and show epigenetic and splicing defects in cancerRNA, 2007
- The transcriptional repressor NIPP1 is an essential player in EZH2-mediated gene silencingOncogene, 2007
- Chemotherapy resistance of mouse WAP-SVT/t breast cancer cells is mediated by osteopontin, inhibiting apoptosis downstream of caspase-3Oncogene, 2006
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005
- Isolation and Characterization of Human NBL4, a Gene Involved in the β‐Catenin/Tcf Signaling PathwayJapanese Journal of Cancer Research, 2000
- Identification of the TCL6 genes within the breakpoint cluster region on chromosome 14q32 in T-cell leukemiaOncogene, 2000